郑跃文 ZHENG Yuewen
Chairman of the CABC, Chairman of the CICCPS
Chairman of the Creat Group
行业: 投资 Sector: Investment
The Creat Group has businesses in both domestic and international markets through direct investing and fund investing, including the areas of manufacturing, pharmaceuticals , mineral resources, etc; The Creat Group has 6 listed companies in following areas, including agriculture, food-processing, electrical equipment, overseas mining and pharmaceuticals. Shanghai RAAS Blood Products Co., Ltd, one of the listed companies, has valued at 6.5 billion dollars on the Shanghai Stock Exchange.
The core valuation of Creat Group is: Credibility, Win-Win Cooperation, Innovation and tenacity.
Dr. Zheng Yuewen always visits Africa. Each year, he travels to different countries of the world to attend international conferences. He got rich experience in the field of international economic cooperation. Mr. Zheng successively received the award for “Most Innovative People’s Award to commemorate China’s Reform and Opening Up for the last 30 years” and the award of “2013 Annual Best Investor of China Overseas Investment”.
Mr. Zheng Yuewen has served as a member of All-China Federation of Industry and Commerce (ACFIC). Currently, he serves as a member of the national committee of CPPCC, and Special Supervisor of Ministry of Supervison of the Peoples Republic of China. Also, He is the second Chairman of China-Africa Business Council(CABC). CABC is the first Chamber of Commerce upon registration in Ministry of Civil Affairs, which actively pursuing to serve and guide Chinese enterprises in their process of “going abroad”. Nowadays, CABC serves over 500 Chinese enterprises who has businesses in Africa. What is more, Mr. Zheng Yuewen is the first Chairman of China International Chamber of Commerce for the Private Sector(CICCPS). CICCPS is the first national Chamber of Commerce that serving private sectors to do overseas businesses, and CICCPS has concentrated on setting the top 500 private enterprises as a membership base.